Selegiline protects dopaminergic neurons in culture from toxic factor(s) present in the cerebrospinal fluid of patients with Parkinson's disease
- 1 November 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 200 (2) , 77-80
- https://doi.org/10.1016/0304-3940(95)12113-i
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Lack of protective effect of R(-)-deprenyl on programmed cell death of mouse thymocytes induced by dexamethasoneLife Sciences, 1995
- L-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brainNeuroReport, 1993
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's diseaseAnnals of Neurology, 1991
- Epidermal Growth Factor Enhances Striatal Dopaminergic Parameters in the 1‐Methyl‐4‐Phenyl‐l, 2, 3, 6‐Tetrahydropyridine‐Treated MouseJournal of Neurochemistry, 1991
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Striatal Homogenates from Animals Chronically Treated with Haloperidol Stimulate Dopamine and GABA Uptake in Cultures of Rostral Mesencephalic TegmentumClinical Neuropharmacology, 1989
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- 1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in cultureNeuroscience Letters, 1985